Global healthcare data technology company, Prospection, has successfully raised $45 million from institutional investors in a Series B round, cornerstoned by new investor Ellerston JAADE with participation from existing shareholders Main Sequence and Horizons Ventures.

Prospection uses real world data, powering evidence to deliver better patient outcomes. Prospection has a growing customer-base which includes 36 multinational companies in Australia, New Zealand, Japan, South Korea and China, and has an early presence in the United Kingdom and United States. Prospection is a key part of achieving this goal and we’re thrilled to continue our support of its journey to enhance patient care and offer healthcare providers tangible insights to determine the best treatment,” said Bill Bartee, Managing Partner at Main Sequence.

Prospection Secures $45 Million To Accelerate Growth Of Its Powerful Healthcare Insights Technology

Description

Company Information

Funding Insights

Prospection Secures $45 Million To Accelerate Growth Of Its Powerful Healthcare Insights Technology

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Funding Insights

Company Information